Schumock and Thornton criteria | Long LOS, N = 383, n (%) | Short LOS, N = 103, n (%) | Total, N = 486, n (%) |
---|---|---|---|
Section A: Definitely preventable ADEs | |||
Was there a history of allergy or previous reaction to the drug? | 4 (1.0) | 5 (4.9) | 9 (1.9) |
Was the drug involved inappropriate for the patient’s clinical condition? | 100 (26.1) | 14 (13.6) | 114 (23.5) |
Was the dose, route, or frequency of administration inappropriate for patient’s age, weight or disease state? | 53 (13.8) | 11 (10.7) | 64 (13.2) |
Was toxic serum drug concentration or lab monitoring test documented? | 7 (1.8) | 9 (8.7) | 16 (3.3) |
Was there a known treatment for ADEs? | 7 (1.8) | 2 (1.9) | 9 (1.9) |
Total | 171 (44.7) | 41 (39.8) | 212 (43.6) |
Section B: Probably preventable ADEs | |||
Was therapeutic drug monitoring or other necessary lab test not performed? | 31 (8.1) | 7 (6.8) | 38 (7.8) |
Was the drug interaction involved in ADEs? | 4 (1.0) | 2 (1.9) | 6 (1.2) |
Was poor compliance involved in ADE? | 13 (3.4) | 4 (3.9) | 17 (3.5) |
Were preventative measures not prescribed or administered to the patient? | 8 (2.1) | 3 (2.9) | 11 (2.3) |
Total | 56 (14.6) | 16 (15.5) | 72 (14.8) |
Total (preventable ADEs) | 227 (59.3) | 57 (55.3) | 284 (58.4) |
Section C: Non-preventable ADEs or ADRs | |||
If all the above criteria not fulfilled. | 156 (40.7) | 46 (44.7) | 202 (41.6) |